Web Results


Atchison et al., 1990. M.L. Atchison, V. Delmas, R.P. PerryA novel upstream element compensates for an ineffectual octamer motif in an immunoglobulin Vκ promoter. Eur. molec. .... al., 1985. D.L. Shawler, R.M. Bartholomew, L.M. Smith, R.O. DillmanHuman immune response to multiple injections of murine monoclonal IgG.


Carrasquillo et al., 1988b. J.A. Carrasquillo, P. Sugarbaker, D. Colcher, J.C. Reynolds, J. Esteban, G. Bryant, P. Perentesis, K. Ykoyama, M. Rotman, J. Schlom, S.M. LarsonPeritoneal carcinomatosis: imaging with intraperitoneal injection of I-131-labeled B72.3 monoclonal antibody. Radiology, 167 (1988), pp. 35-40.


773-783. Khazaeli et al., 1994. M.B. Khazaeli, K. Safavy, A.R. LoBuglioLow V- region immunogenicity of therapeutic doses of 131I-LL2 mouse monoclonal antibody in lymphoma patients .... D.L. Shawler, R.M. Bartholomew, L.M. Smith, R.O. DillmanHuman immune response to multiple injections of murine monoclonal IgG.


Slamon et al, 1989). However, the expression of this gene in normal adult tissues is weak (De Potter et al, 1989; Press et al,. 1990). Therefore, the HER2 product is thought to be a useful target for ... murine mabs (Schroff et al, 1985; Shawler et al, 1985). .... distribution volume (V) and serum clearance (CL) were estimated.


Jan 29, 2018 ... Justin Shawler, Appellant vs. Big Valley, LLC. *No. 17-30362. Danny Barefoot, Appellant vs. Weyerhaeuser NR Co. TUESDAY, MARCH 6, 2018 – COURT CONVENES AT 9:00 AM. *No. 16-41692. United States of America vs. Juan Antonio Compian, Appellant. *No. 17-60315. Mary L. Hatcher, Et Al., ...


Rosenberg SA , Lotze MT , Muul LM et al . N. Engl. J. Med. 1987 ; 316 : 889 – 97 . Show context. Google Scholar ... Fakhrai H , Shawler DL , Gjerset R et al . Human Gene Therapy 1995 ; 6 : 591 – 601 . ... Centre, Nedlands, Western Australia, Australia. Clement C Leong; , Julia V Marley; , Suzanne Loh; & Michael J Garlepp  ...


Oct 20, 2016 ... The wound age in months (±STDev) for the healed and unheald DFUs was as follows: mean ulcer age – healed DFUs = 18.0 months (±16.1) versus unhealed DFUs = 19.2 months (±19.2). The mean ..... Chmielowiec J., Borowiak M., Morkel M., et al. c-Met is essential for wound healing in the skin. Journal of ...


Jun 5, 2015 ... The Met kinase was originally identified as a transforming oncoprotein activated by gene rearrangement induced by a carcinogen (Park et al., 1986). ..... The expected human anti-murine antibody reaction (Shawler et al., 1985) was minimized by substitution of the murine constant regions of the antibody ...


Immunotherapy has emerged in recent years as a promising therapeutic approach in lung cancer. Two approaches are of particular interest: immune checkpoint inhibition, which aims to counteract the physiologic mechanisms of immune tolerance co-opted by some tumors, and vaccine therapy, which enables enhanced ...